Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV003740795 | SCV004557702 | pathogenic | Charcot-Marie-Tooth disease, type I | 2023-07-28 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the MPZ protein in which other variant(s) (p.Lys236del) have been determined to be pathogenic (PMID: 12207932, 15716547, 29687021, 31173589). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with MPZ-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change results in a frameshift in the MPZ gene (p.Leu170Cysfs*81). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 79 amino acid(s) of the MPZ protein and extend the protein by 1 additional amino acid residues. |